CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 28, 2013	Dec. 29, 2012
Operating activities:
Net income	$ 4,819	$ 7,323
Adjustments to reconcile net income to cash (used in) provided by operating activities:
Depreciation and amortization	1,786	1,270
Excess tax benefit from exercise of stock options	(134)	(103)
Provision for obsolete inventory	171	355
Provision for warranty	6	0
Provision for doubtful accounts	0	22
Gain (Loss) on Disposition of Assets	5	31
Share-based compensation expense	335	425
Deferred income taxes	(1,728)	1,972
Changes in operating assets and liabilities:
Trade receivables	(4,426)	5,890
Inventories	(1,694)	8,939
Other assets	(81)	(1,866)
Accounts payable	1,379	(11,356)
Accrued compensation and vacation	(1,500)	(1,010)
Other liabilities	518	524
Cash (used in) provided by operating activities	(544)	12,416
Investing activities:
Acquisition of Sabre	(6,027)	0
Proceeds from Life Insurance Policies	0	144
Purchase of property and equipment	(2,608)	(2,215)
Cash used in investing activities	(8,635)	(2,071)
Financing activities:
Payments of Financing Costs	(11)	(75)
Principal payments on capital lease obligations	(380)	(359)
Borrowings under revolving credit agreement	0	57,797
Repayment of revolving credit agreement	0	(68,077)
Excess tax benefit from exercise of stock options	134	103
Proceeds from exercise of stock options	50	9
Cash used in financing activities	(207)	(10,602)
Net decrease in cash and cash equivalents	(9,386)	(257)
Cash and cash equivalents, beginning of period	10,819	502
Cash and cash equivalents, end of period	1,433	245
Supplemental cash flow information:
Interest payments	44	231
Income tax payments, net of refunds	$ 987	$ 868